John Dingell actually said...

"I have got some legislation to address that and I hope that we will be shortly addressing it here in this committee."

"Do you have authority at FDA or at HHS to waive any of the requirements with regard to efficacy, good manufacturing practices, or safety, yes or no, in the event of shortage?"

"I have a bill that would require manufacturers to maintain records establishing where the drug and its raw materials were produced."

"It is my understanding that the FDA has been working to address shortages of medically necessary drugs."